STREPTASE FOR INJECTION 1,500,000 iu/vial
Country: Singapore
Language: English
Source: HSA (Health Sciences Authority)
Patient Information leaflet
(PIL)
19-10-2007
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
STREPTOKINASE
Available from:
UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED
ATC code:
B01AD01
Dosage:
1500000 iu/vial
Pharmaceutical form:
INJECTION, POWDER, FOR SOLUTION
Administration route:
INTRAVENOUS
Prescription type:
Prescription Only
Manufactured by:
CSL BEHRING GMBH
Authorization date:
1988-04-30
Patient Information leaflet
CSL BEHRING
STREPTASE® 1 500 000
PI/CORE/ENGLISH, REV.: 02-JAN-2007 / CSL BEHRING
CSL Behring
Page 1 of 11
Streptase for Injection 1500000IU per vial PI
PACKAGE INSERT
Dear Patient,
This leaflet gives you important information about this medicine. It is continually updated.
Therefore, PLEASE READ THIS LEAFLET CAREFULLY. Unfortunately, one cannot explain all the medical
knowledge relating to your disease in such a small leaflet. This is why you might not understand
every part of it without a comprehensive medical background or a personal explanation from your
doctor. For this reason this leaflet also provides specialized information for your doctor, so that he
can help you to understand.
If you have further questions about this medicine or any questions about your disease, please ask
your doctor or pharmacist.
STREPTASE
®
1 500 000
ACTIVE INGREDIENT: Stabilized pure streptokinase, derived from
the culture filtrate of beta-
haemolytic streptococci of Lancefield group C. It is presented as a
white powder and contains
stabilizers.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE INGREDIENTS
1 injection vial with 147 to 192 mg dried substance contains 1 500
000 IU streptokinase.
OTHER INGREDIENTS
Human albumin, sodium-L-hydrogen glutamate monohydrate, polygeline
PHARMACEUTICAL FORM AND PRESENTATIONS
PHARMACEUTICAL FORM
Powder for intravenous or intraarterial administration after
reconstitution with physiological
saline.
PRESENTATIONS
Streptase 1 500 000
1 vial of 1 500 000 IU streptokinase
PHARMACOTHERAPEUTIC GROUP
Streptokinase (antithrombotic agents, enzymes)
ATC-code: B01A D01
CSL BEHRING
STREPTASE® 1 500 000
PI/CORE/ENGLISH, REV.: 02-JAN-2007 / CSL BEHRING
CSL Behring
Page 2 of 11
Strept
Read the complete document
